Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new revision entry (v3.5.4) appears, replacing v3.5.3 in the history. This indicates an administrative update to the page's revision metadata in ClinicalTrials.gov.SummaryDifference0.0%

- Check14 days agoChange DetectedNew Study Status entries were added to the history for 2026-04-14 and 2026-05-05, with the 2026-05-05 entry including '87', and the 2026-02-06 entry was removed. These updates reflect changes to the study's recorded status on the history page.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s interface/update footer revision label has been advanced from v3.5.2 to v3.5.3, indicating a minor platform release rather than a change to the clinical trial record itself.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check50 days agoChange DetectedLatest version updates core study details such as Study Status and Contacts/Locations, reflecting current recruitment status and site information.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the history.SummaryDifference0.0%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.